PMV Pharmaceuticals, Inc. (PMVP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 34K | 0 | 0 | 32K | 0 | 0 | 0 | 372K | 362K | 359K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -34K | 0 | 0 | -32K | 0 | 0 | 0 | -372K | -362K | -359K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 91.4% | 100% | 100% | - | - | - | - | - | - |
| Operating Expenses | 18.98M | 19.24M | 22.52M | 22.85M | 21.56M | 25.17M | 21.89M | 19.8M | 17.86M | 18.54M | 19.63M | 20.12M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 3.69M | 3.42M | 4.31M | 4.48M | 4.12M | 11.4M | 4.94M | 5.54M | 5.04M | 5.52M | 6.04M | 6.28M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 15.3M | 15.83M | 18.21M | 18.37M | 17.44M | 13.77M | 16.95M | 14.26M | 12.82M | 13.02M | 13.59M | 13.84M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17K | -1K | 0 | 0 | 0 |
| Operating Income | -19.02M | -19.24M | -22.52M | -22.88M | -21.56M | -25.17M | -21.89M | -20.17M | -18.22M | -18.9M | -19.63M | -20.12M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 11.8% | 23.55% | -2.9% | -13.43% | -18.35% | -33.15% | -11.51% | -0.24% | 15.17% | 10.68% | -1.31% | -12.51% |
| EBITDA | -18.98M | -19.21M | -22.49M | -22.85M | -21.53M | -25.13M | -21.52M | -19.8M | -17.86M | -18.54M | -19.27M | -19.75M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 11.81% | 23.56% | -4.53% | -15.4% | -20.54% | -35.52% | -11.66% | -0.23% | 16.19% | 12.06% | 0.16% | -10.95% |
| D&A (Non-Cash Add-back) | 34K | 33K | 31K | 32K | 37K | 39K | 371K | 372K | 362K | 359K | 358K | 369K |
| EBIT | -19.02M | -19.24M | -22.52M | -21.2M | -21.56M | -25.17M | -21.89M | -20.17M | -18.22M | -15.76M | -19.63M | -20.12M |
| Net Interest Income | 980K | 1.23M | 1.48M | 1.69M | 1.94M | 2.29M | 2.62M | 2.8M | 2.95M | 3.17M | 2.98M | 2.7M |
| Interest Income | 980K | 1.23M | 1.48M | 1.69M | 1.94M | 2.29M | 2.62M | 2.8M | 2.95M | 3.17M | 2.98M | 2.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 981K | 1.23M | 1.46M | 1.67M | 1.93M | 2.17M | 2.74M | 2.78M | 2.95M | 3.15M | 2.99M | 2.69M |
| Pretax Income | -18.04M | -18.01M | -21.07M | -21.2M | -19.63M | -23M | -19.15M | -17.39M | -15.27M | -15.76M | -16.64M | -17.43M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 26K | -6K | 5K | -2.2M | 0 | 74K | -16.17M | 0 | -1K | 0 | 4K |
| Effective Tax Rate % | 0% | -0.14% | 0.03% | -0.02% | 11.19% | 0% | -0.39% | 93.02% | 0% | 0.01% | 0% | -0.02% |
| Net Income | -18.04M | -18.04M | -21.06M | -21.21M | -17.44M | -23M | -19.23M | -1.21M | -15.27M | -15.76M | -16.64M | -17.44M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -3.45% | 21.58% | -9.53% | -1648.56% | -14.18% | -45.98% | -15.54% | 93.04% | 20.17% | 18.55% | 8.72% | -0.73% |
| Net Income (Continuing) | -18.04M | -18.04M | -21.06M | -21.21M | -17.44M | -23M | -19.23M | -1.21M | -15.27M | -15.76M | -16.64M | -17.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.34 | -0.34 | -0.40 | -0.41 | -0.34 | 0.37 | -0.37 | -0.02 | -0.30 | -0.31 | -0.34 | -0.38 |
| EPS Growth % | 0% | -191.89% | -8.11% | -1950% | -13.33% | 220.81% | -8.82% | 94.74% | 28.57% | 27.65% | 15% | 0% |
| EPS (Basic) | -0.34 | -0.34 | -0.40 | -0.41 | -0.34 | 0.37 | -0.37 | -0.02 | -0.30 | -0.31 | -0.34 | -0.38 |
| Diluted Shares Outstanding | 53.33M | 53.28M | 52.99M | 52.01M | 51.95M | 51.57M | 51.57M | 51.48M | 51.45M | 51.45M | 49.05M | 45.81M |
| Basic Shares Outstanding | 53.33M | 53.28M | 52.99M | 52.01M | 51.95M | 51.57M | 51.57M | 51.48M | 51.45M | 51.45M | 49.05M | 45.81M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |